IL225179A0 - Compositions for use in treating eye disorders using dipyridamole - Google Patents

Compositions for use in treating eye disorders using dipyridamole

Info

Publication number
IL225179A0
IL225179A0 IL225179A IL22517913A IL225179A0 IL 225179 A0 IL225179 A0 IL 225179A0 IL 225179 A IL225179 A IL 225179A IL 22517913 A IL22517913 A IL 22517913A IL 225179 A0 IL225179 A0 IL 225179A0
Authority
IL
Israel
Prior art keywords
dipyridamole
compositions
eye disorders
treating eye
treating
Prior art date
Application number
IL225179A
Other languages
Hebrew (he)
Other versions
IL225179A (en
Original Assignee
Moshe Rogosnitzky
Remedeye Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moshe Rogosnitzky, Remedeye Inc filed Critical Moshe Rogosnitzky
Priority to IL225179A priority Critical patent/IL225179A/en
Publication of IL225179A0 publication Critical patent/IL225179A0/en
Priority to PCT/IB2014/059645 priority patent/WO2014141079A1/en
Priority to EP14764673.1A priority patent/EP2968328A4/en
Priority to KR1020157027571A priority patent/KR20150126021A/en
Priority to MYPI2015002196A priority patent/MY182591A/en
Priority to CA2905594A priority patent/CA2905594A1/en
Priority to SG11201507092QA priority patent/SG11201507092QA/en
Priority to AU2014229371A priority patent/AU2014229371B2/en
Priority to EA201591653A priority patent/EA035966B1/en
Priority to BR112015022084A priority patent/BR112015022084A2/en
Priority to JP2015562486A priority patent/JP6820658B2/en
Priority to KR1020217001495A priority patent/KR20210010638A/en
Priority to SG10201706937UA priority patent/SG10201706937UA/en
Priority to MX2015012716A priority patent/MX2015012716A/en
Priority to CN201480016302.6A priority patent/CN105188702B/en
Priority to US14/483,181 priority patent/US20150031712A1/en
Priority to CL2015002627A priority patent/CL2015002627A1/en
Publication of IL225179A publication Critical patent/IL225179A/en
Priority to US15/428,709 priority patent/US9901580B2/en
Priority to US15/826,725 priority patent/US10226420B2/en
Priority to US16/236,525 priority patent/US10357453B2/en
Priority to US16/444,025 priority patent/US10973758B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL225179A 2013-03-12 2013-03-12 Compositions for use in treating eye disorders using dipyridamole IL225179A (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
IL225179A IL225179A (en) 2013-03-12 2013-03-12 Compositions for use in treating eye disorders using dipyridamole
CN201480016302.6A CN105188702B (en) 2013-03-12 2014-03-11 Compositions for treating ocular diseases using dipyridamole
JP2015562486A JP6820658B2 (en) 2013-03-12 2014-03-11 Compositions for use in the treatment of eye diseases with dipyridamole
SG10201706937UA SG10201706937UA (en) 2013-03-12 2014-03-11 Compositions for Use in Treating Eye Disorders Using Dipyridamole
KR1020157027571A KR20150126021A (en) 2013-03-12 2014-03-11 Compositions for use in treating eye disorders using dipyridamole
MYPI2015002196A MY182591A (en) 2013-03-12 2014-03-11 Compositions for use in treating eye disorders using dipyridamole
CA2905594A CA2905594A1 (en) 2013-03-12 2014-03-11 Compositions for use in treating eye disorders using dipyridamole
SG11201507092QA SG11201507092QA (en) 2013-03-12 2014-03-11 Compositions for use in treating eye disorders using dipyridamole
AU2014229371A AU2014229371B2 (en) 2013-03-12 2014-03-11 Compositions for use in treating eye disorders using dipyridamole
EA201591653A EA035966B1 (en) 2013-03-12 2014-03-11 Use of a pharmaceutical composition for topical application in treating lacrimal system and anterior segment of the eye disorders
BR112015022084A BR112015022084A2 (en) 2013-03-12 2014-03-11 compositions for use in treating eye disorders with the use of dipyridamole
PCT/IB2014/059645 WO2014141079A1 (en) 2013-03-12 2014-03-11 Compositions for use in treating eye disorders using dipyridamole
KR1020217001495A KR20210010638A (en) 2013-03-12 2014-03-11 Compositions for use in treating eye disorders using dipyridamole
EP14764673.1A EP2968328A4 (en) 2013-03-12 2014-03-11 Compositions for use in treating eye disorders using dipyridamole
MX2015012716A MX2015012716A (en) 2013-03-12 2014-03-11 Compositions for use in treating eye disorders using dipyridamole.
US14/483,181 US20150031712A1 (en) 2013-03-12 2014-09-11 Therapeutic Compositions Containing Dipyridamole and Treatment Packs Including Such Compositions and Methods for Producing Same
CL2015002627A CL2015002627A1 (en) 2013-03-12 2015-09-11 Compositions for use in the treatment of eye disorders using dipyridamole
US15/428,709 US9901580B2 (en) 2013-03-12 2017-02-09 Methods of eye treatment using therapeutic compositions containing dipyridamole
US15/826,725 US10226420B2 (en) 2013-03-12 2017-11-30 Methods of eye treatment using therapeutic compositions containing dipyridamole
US16/236,525 US10357453B2 (en) 2013-03-12 2018-12-30 Methods of eye treatment using therapeutic compositions containing dipyridamole
US16/444,025 US10973758B2 (en) 2013-03-12 2019-06-18 Methods of eye treatment using therapeutic compositions containing dipyridamole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL225179A IL225179A (en) 2013-03-12 2013-03-12 Compositions for use in treating eye disorders using dipyridamole

Publications (2)

Publication Number Publication Date
IL225179A0 true IL225179A0 (en) 2013-06-27
IL225179A IL225179A (en) 2017-01-31

Family

ID=48916407

Family Applications (1)

Application Number Title Priority Date Filing Date
IL225179A IL225179A (en) 2013-03-12 2013-03-12 Compositions for use in treating eye disorders using dipyridamole

Country Status (14)

Country Link
EP (1) EP2968328A4 (en)
JP (1) JP6820658B2 (en)
KR (2) KR20210010638A (en)
CN (1) CN105188702B (en)
AU (1) AU2014229371B2 (en)
BR (1) BR112015022084A2 (en)
CA (1) CA2905594A1 (en)
CL (1) CL2015002627A1 (en)
EA (1) EA035966B1 (en)
IL (1) IL225179A (en)
MX (1) MX2015012716A (en)
MY (1) MY182591A (en)
SG (2) SG10201706937UA (en)
WO (1) WO2014141079A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6925272B2 (en) * 2015-01-28 2021-08-25 リアルイン ライフ サイエンス リミテッド Compounds that promote PPARγ expression and nuclear translocation and their therapeutic use
US20180092776A1 (en) 2016-09-30 2018-04-05 Sara Heikali Method and device for treating and managing diseased ocular tissue
WO2021001806A1 (en) 2019-07-04 2021-01-07 Ocular Discovery Ltd. Stable dipyridamole formulations with reduced impurities
WO2021001805A1 (en) 2019-07-04 2021-01-07 Ocular Discovery Ltd. Stable dipyridamole formulations and their methods of preparation
WO2024125322A1 (en) * 2022-12-16 2024-06-20 智泽童康(广州)生物科技有限公司 Dipyridamole for preventing and treating allergic and/or inflammatory diseases and preparation thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07258084A (en) * 1994-03-17 1995-10-09 Rohto Pharmaceut Co Ltd Intracular pressure-reducing agent containing dipyridamole as essential component
US5780450A (en) * 1995-11-21 1998-07-14 Alcon Laboratories, Inc. Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
EP2218442A1 (en) * 2005-11-09 2010-08-18 CombinatoRx, Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
WO2010056710A1 (en) * 2008-11-11 2010-05-20 Biovista, Inc. Compositions and methods for treating eye diseases
EP2363126A1 (en) * 2010-03-04 2011-09-07 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation

Also Published As

Publication number Publication date
BR112015022084A2 (en) 2017-07-18
MX2015012716A (en) 2016-07-06
JP6820658B2 (en) 2021-01-27
EA201591653A1 (en) 2017-05-31
AU2014229371A1 (en) 2015-10-29
EP2968328A4 (en) 2016-11-23
SG10201706937UA (en) 2017-09-28
CN105188702A (en) 2015-12-23
WO2014141079A1 (en) 2014-09-18
IL225179A (en) 2017-01-31
KR20210010638A (en) 2021-01-27
CL2015002627A1 (en) 2016-03-11
JP2016514123A (en) 2016-05-19
CA2905594A1 (en) 2014-09-18
AU2014229371B2 (en) 2018-05-10
KR20150126021A (en) 2015-11-10
MY182591A (en) 2021-01-26
SG11201507092QA (en) 2015-10-29
CN105188702B (en) 2019-03-26
EA035966B1 (en) 2020-09-07
EP2968328A1 (en) 2016-01-20

Similar Documents

Publication Publication Date Title
HK1225305A1 (en) Methods and compositions for treating brain diseases
PT3811943T (en) Compound for use in the treatment of ocular disorders
HK1203830A1 (en) Compositions and methods for treating metabolic disorders
RS64141B1 (en) Tetrahydropyranyl amino-pyrrolopyrimidinone for use in treating btk-mediated disorders
HK1217650A1 (en) Compositions and methods for treating severe pain
EP2989123A4 (en) Methods and compositions for treating bleeding disorders
SG10201710538XA (en) Compositions and methods for treating skin
IL242584B (en) Immunogenic composition for use in therapy
PL3041831T3 (en) Alpha-tea salt forms: compositions and uses for treating disease
SG10201706937UA (en) Compositions for Use in Treating Eye Disorders Using Dipyridamole
EP2968452A4 (en) Compositions and methods for treating retinal disease
IL311363A (en) Compositions for use in treating cognitive impairment
GB201308753D0 (en) Compounds and their use in therapy
EP2978452A4 (en) Compositions and methods for treating osteolytic bone disorders
IL238363A0 (en) Methods for treating eye disorders
SI2815740T1 (en) Ophthalmic composition
ZA201508585B (en) Immunogenic composition for use in therapy
GB201304675D0 (en) Novel compositions having use in therapy
GB201314623D0 (en) Novel mucinase for use in therapy or prophylaxis
GB201223371D0 (en) Novel mucinase for use in therapy or prophylaxis
GB201308217D0 (en) Compounds and their use in therapy

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed